CA
NZ
UK
AU
IND
US
Allot Ltd. Announced its board has authorized a $40 million share repurchase program, a move aimed at enhancing shareholder value while maintaining investment in long-term growth. The decision follows a year of consecutive quarterly expansion and improved profitability, underscoring the company’s financial momentum.
AmpliTech Group has shifted its capital allocation strategy, moving away from a previously negotiated financing structure toward a share repurchase approach. This change underscores a recalibration of priorities in response to current market dynamics.
This capital deployment pushed non‑current debt to $39.3 billion, up from a much lower prior level, reflecting the firm’s willingness to finance the buyback through additional leverage.
PowerFleet Inc. The authorization, effective June 30, allows the company to buy back shares over the next two years, aligning with its broader capital allocation objectives.
Dravica Corp has implemented key leadership changes, introducing a new chief executive while adjusting its executive team composition. These moves indicate a deliberate effort to refine the company’s strategic direction.
Jack in the Box Inc. Disclosed a key leadership change affecting its supply chain operations. The fast-food chain confirmed Carl Mount will leave his current executive position in mid-2026. This transition reflects a planned exit rather than an unexpected change.
GMR Solutions Inc. (NYSE: GMRS) has completed a key leadership transition, naming a new board chair and assigning committee roles as part of broader governance updates. The changes, effective this month, reflect the company’s ongoing efforts to refine its oversight structure amid evolving market …
Crisp Momentum Inc. (OTC: CRSF) disclosed a significant leadership reshuffle in a filing with the U.S. Securities and Exchange Commission. The changes, effective June 30, 2026, include the departure of its chief executive and the appointment of an interim CEO, as well as a …
Genworth Financial has disclosed a temporary change in its top leadership as its current chief executive steps away for health reasons. The company stated that Thomas McInerney will take a leave of absence starting July 7, 2026, though no specific end date was provided. …
MacroGenics (NASDAQ: MGNX) has completed the sale of its contract development and manufacturing organization (CDMO) operations to Bora Pharmaceuticals. The transaction, finalized in mid-2026, transfers key manufacturing and logistics assets in Maryland to the Taiwan-based pharmaceutical company. The move was disclosed in a regulatory …
Please wait processing your request...